CME Group Inc. $CME Shares Sold by Summit Global Investments

Summit Global Investments decreased its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 15.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,060 shares of the financial services provider’s stock after selling 2,408 shares during the quarter. Summit Global Investments’ holdings in CME Group were worth $3,529,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Caldwell Trust Co grew its stake in CME Group by 116.3% in the 3rd quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 50 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new position in shares of CME Group during the 3rd quarter worth approximately $27,000. Financial Consulate Inc. purchased a new stake in CME Group in the 3rd quarter valued at $28,000. Sagard Holdings Management Inc. purchased a new stake in shares of CME Group in the second quarter valued at about $30,000. Finally, Corundum Trust Company INC acquired a new stake in shares of CME Group during the 3rd quarter worth approximately $30,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

More CME Group News

Here are the key news stories impacting CME Group this week:

  • Positive Sentiment: Analysts and data services expect a likely earnings beat ahead of CME’s upcoming release (market consensus/non‑GAAP EPS previews and previews noting the company’s revenue mix). Positive guidance/expectations ahead of the report are supporting the stock. Will CME Group (CME) beat quarterly earnings? CME Group (CME) Earnings Expected to Grow
  • Positive Sentiment: CME expanded crypto derivatives with options on its Bitcoin Friday futures, broadening products for institutional and retail-facing flows — potential to increase volumes and fee revenue as crypto activity grows. CME Group Expands Crypto Offerings With Options On Bitcoin Friday Futures
  • Positive Sentiment: CME issued a self‑certification that could let FanDuel and DraftKings offer Super Bowl parlays on prediction markets using CME infrastructure — a new use case that could drive volume and broaden commercial relationships. FanDuel and DraftKings prediction markets could offer Super Bowl parlays, as CME issues self-certification
  • Positive Sentiment: Reported short interest fell earlier in January (down ~15.6% to ~4.21M shares as of Jan 15), reducing potential downside pressure from short-covering and signaling less bearish positioning. (Data feed)
  • Neutral Sentiment: CME signed a multiyear jersey-patch sponsorship with the Chicago White Sox — increases brand visibility in its hometown market but likely a modest near-term financial impact relative to core derivatives revenue. CME Group Named as First-Ever Chicago White Sox Jersey Patch Sponsor
  • Neutral Sentiment: There is an anomalous/erroneous short‑interest entry showing zero shares for late‑January that appears to be a reporting error — investors should rely on the earlier, validated short‑interest update. (Data feed)

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. JPMorgan Chase & Co. increased their price target on CME Group from $256.00 to $262.00 and gave the stock an “underweight” rating in a report on Thursday, January 22nd. Bank of America boosted their target price on CME Group from $201.00 to $209.00 in a research report on Wednesday, December 10th. Barclays raised their price target on CME Group from $280.00 to $304.00 and gave the stock an “equal weight” rating in a research report on Friday, December 12th. Raymond James Financial increased their target price on CME Group from $307.00 to $311.00 and gave the stock an “outperform” rating in a research note on Monday, January 5th. Finally, Morgan Stanley lowered their target price on CME Group from $320.00 to $319.00 and set an “overweight” rating for the company in a report on Thursday, January 15th. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $292.18.

View Our Latest Analysis on CME Group

Insider Buying and Selling

In other news, Director William R. Shepard acquired 251 shares of CME Group stock in a transaction dated Tuesday, December 30th. The shares were acquired at an average cost of $278.37 per share, for a total transaction of $69,870.87. Following the acquisition, the director owned 258,710 shares of the company’s stock, valued at $72,017,102.70. This trade represents a 0.10% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Terrence A. Duffy sold 25,000 shares of the business’s stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the transaction, the chief executive officer owned 65,804 shares of the company’s stock, valued at approximately $17,737,468.20. The trade was a 27.53% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is owned by insiders.

CME Group Price Performance

Shares of NASDAQ CME opened at $289.83 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market cap of $104.51 billion, a price-to-earnings ratio of 28.08, a price-to-earnings-growth ratio of 3.22 and a beta of 0.27. The stock’s 50-day moving average is $274.93 and its two-hundred day moving average is $272.27. CME Group Inc. has a 1-year low of $233.12 and a 1-year high of $291.76.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 30th. Investors of record on Friday, December 12th were issued a $1.25 dividend. The ex-dividend date of this dividend was Friday, December 12th. This represents a $5.00 annualized dividend and a yield of 1.7%. CME Group’s dividend payout ratio (DPR) is 48.45%.

CME Group Company Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Read More

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.